We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 5579N
GlaxoSmithKline PLC
26 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
=== ======================================================================
a) Name Sir Philip Hampton
=== ======================== ============================================
b) Position/status Non-Executive Chairman
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 2,662.812
---------- ----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2016-10-26
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Professor Sir Roy Anderson
=== ======================== ===========================================
b) Position/status Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 437.462
---------- ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2016-10-26
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ======================================================================
a) Name Mr Vindi Banga
=== ======================== ============================================
b) Position/status Senior Independent Non-Executive Director
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 1,749.848
---------- ----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2016-10-26
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Ms Stacey Cartwright
=== ======================== ===========================================
b) Position/status Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 323.341
---------- ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2016-10-26
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =====================================================================
a) Name Dr Vivienne Cox
=== ======================== ===========================================
b) Position/status Independent Non-Executive Director
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 323.341
---------- ----------
=== ======================== ===========================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2016-10-26
=== ======================== ===========================================
f) Place of the n/a
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ========================================================================
a) Name Ms Lynn Elsenhans
=== ======================== ==============================================
b) Position/status Independent Non-Executive Director
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ==============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 July 2016 to 30 September
2016.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.70 1,131.786
--------- ----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2016-10-26
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ========================================================================
a) Name Ms Judy Lewent
=== ======================== ==============================================
b) Position/status Independent Non-Executive Director
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ==============================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Independent
Non-Executive Directors for the period
of service from 1 July 2016 to 30 September
2016.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$40.70 454.112
--------- ----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2016-10-26
=== ======================== ==============================================
f) Place of the n/a
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ======================================================================
a) Name Mr Urs Rohner
=== ======================== ============================================
b) Position/status Independent Non-Executive Director
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Independent Non-Executive Directors
for the period of service from 1 July 2016
to 30 September 2016.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) ---------- ----------
GBP16.43 399.422
---------- ----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2016-10-26
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQQLFLQBFBFBV
(END) Dow Jones Newswires
October 26, 2016 12:10 ET (16:10 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
